These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 15336302)
1. Influence of the combined treatment of LY 300164 (an AMPA/kainate receptor antagonist) with adenosine receptor agonists on the electroconvulsive threshold in mice. Borowicz KK; Swiader M; Wielosz M; Czuczwar SJ Eur Neuropsychopharmacol; 2004 Oct; 14(5):407-12. PubMed ID: 15336302 [TBL] [Abstract][Full Text] [Related]
2. LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs. Czuczwar SJ; Swiader M; Kuźniar H; Gasior M; Kleinrok Z Eur J Pharmacol; 1998 Oct; 359(2-3):103-9. PubMed ID: 9832379 [TBL] [Abstract][Full Text] [Related]
3. Influence of agents affecting voltage-dependent calcium channels and dantrolene on the anticonvulsant action of the AMPA/kainate receptor antagonist LY 300164 in mice. Swiader M; Borowicz KK; Porebiak J; Kleinrok Z; Czuczwar SJ Eur Neuropsychopharmacol; 2002 Aug; 12(4):311-9. PubMed ID: 12126870 [TBL] [Abstract][Full Text] [Related]
5. Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam. Borowicz KK; Luszczki J; Szadkowski M; Kleinrok Z; Czuczwar SJ Eur J Pharmacol; 1999 Sep; 380(2-3):67-72. PubMed ID: 10513564 [TBL] [Abstract][Full Text] [Related]
6. Influence of LY 300164, an AMPA/kainate receptor antagonist upon the anticonvulsant action of antiepileptic drugs against aminophylline-induced seizures in mice. Swiader M; Kuźniar H; Kleinrok Z; Czuczwar SJ Pol J Pharmacol; 2003; 55(1):103-7. PubMed ID: 12856833 [TBL] [Abstract][Full Text] [Related]
8. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene. De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606 [TBL] [Abstract][Full Text] [Related]
9. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice. Borowicz KK; Gasior M; Kleinrok Z; Czuczwar SJ Epilepsia; 1996 Jul; 37(7):618-24. PubMed ID: 8681893 [TBL] [Abstract][Full Text] [Related]
10. Intranasal administration of NECA can induce both anti-inflammatory and pro-inflammatory effects in BALB/c mice: evidence for A 2A receptor sub-type mediation of NECA-induced anti-inflammatory effects. El-Hashim AZ; Abduo HT; Rachid OM; Luqmani YA; Al Ayadhy BY; Alkhaledi GM Pulm Pharmacol Ther; 2009 Jun; 22(3):243-52. PubMed ID: 19146972 [TBL] [Abstract][Full Text] [Related]
11. Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor. Patel M; Sheehan MJ; Strong P Br J Pharmacol; 1994 Nov; 113(3):741-8. PubMed ID: 7858863 [TBL] [Abstract][Full Text] [Related]
12. Influence of several convulsants on the protective activity of a non-competitive AMPA/kainate antagonist, LY 300164, and lamotrigine against maximal electroshock in mice. Borowicz KK; Swiader M; Zgrajka W; Sawulski C; Turski WA; Czuczwar SJ J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):859-69. PubMed ID: 12510869 [TBL] [Abstract][Full Text] [Related]
13. The plasma protein extravasation induced by adenosine and its analogues in the rat dorsal skin: evidence for the involvement of capsaicin sensitive primary afferent neurones and mast cells. Esquisatto LC; Costa SK; Camargo EA; Ribela MT; Brain SD; de Nucci G; Antunes E Br J Pharmacol; 2001 Sep; 134(1):108-15. PubMed ID: 11522602 [TBL] [Abstract][Full Text] [Related]
14. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil. Löscher W; Hönack D Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291 [TBL] [Abstract][Full Text] [Related]
15. Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat. Adami M; Bertorelli R; Ferri N; Foddi MC; Ongini E Eur J Pharmacol; 1995 Dec; 294(2-3):383-9. PubMed ID: 8750698 [TBL] [Abstract][Full Text] [Related]
16. Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration. Knapp CM; Foye MM; Cottam N; Ciraulo DA; Kornetsky C Pharmacol Biochem Behav; 2001 Apr; 68(4):797-803. PubMed ID: 11526979 [TBL] [Abstract][Full Text] [Related]
17. Effects of adenosine receptor agonists and antagonists on pentylenetetrazole-induced amnesia. Homayoun H; Khavandgar S; Zarrindast MR Eur J Pharmacol; 2001 Nov; 430(2-3):289-94. PubMed ID: 11711045 [TBL] [Abstract][Full Text] [Related]
18. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model. Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590 [TBL] [Abstract][Full Text] [Related]